Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
By Tom Ulrich
Earlier this month, the American Cancer Society (ACS) released "Cancer Statistics, 2014," their annual estimate of new cancers diagnoses and deaths for the year ahead. The report was heavily focused on adult malignancies – not surprisingly, given that the number of adult cancer patients in the nation is orders of magnitudes greater than that of childhood patients – but did hold a few insights into childhood cancers.
It showed, for instance, that cancer is still the leading cause of disease-related death among children in the U.S. Leukemias, brain and other nervous system tumors, and sarcomas – tumors of the bones, joints and soft tissues – topped the list of the most lethal cancers for both boys and girls.
But that's pretty much where "Cancer Statistics, 2014" left off when it came to childhood cancers. However, the ACS also released a separate report in December – "Annual Report to the Nation on the status of cancer, 1975-2010" – that held a bit more news when it came to the recent pediatric cancer trends in the U.S.